Lucid Group, Inc. (LCID)
Lucid Group issued a press release announcing Q2 2026 production and delivery totals of 4,774 vehicles produced and 3,953 delivered.
View raw filing on EDGAR →Filings Radar
SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
HOME BANCORP, INC. (HBCP)
The filing discloses the Company's plan to issue its earnings release for the quarter ended June 30, 2026, on July 20, 2026, and host a conference call on July 21, 2026 with Chairman and CEO John W. Bordelon, President Darren E. Guidry, and CFO David T. Kirkley to discuss second quarter results. Although this is technically an announcement of a future earnings release rather than the release itself, the substance is a disclosure of material quarterly financial results, which is a standard earnings_release event.
View raw filing on EDGAR →HORIZON BANCORP INC /IN/ (HBNC)
The filing discloses an announcement that Horizon Bancorp will release its second quarter 2026 financial results after market close on July 22, 2026, with a management conference call scheduled for July 23, 2026. The press release (Exhibit 99.1) explicitly states "Horizon Bancorp, Inc. Announces Conference Call to Review Second Quarter Results," which is a standard earnings release notification. This is a material disclosure of quarterly financial results typical of Item 2.02 filings.
View raw filing on EDGAR →BIOGEN INC. (BIIB)
Biogen discloses preliminary unaudited financial results for Q2 2026 and provides guidance for Q3 2026, including specific charges ($164M for Q2, $290-320M for Q3) and their impact on GAAP and non-GAAP earnings per share ($0.95 and $1.75-1.95 respectively). While the disclosure focuses on acquired in-process R&D and milestone expenses rather than comprehensive earnings, it constitutes a material financial results disclosure under Item 2.02 that would affect investor assessment of quarterly performance.
View raw filing on EDGAR →British American Tobacco p.l.c. (BTAFF)
British American Tobacco disclosed H1 2026 financial results and full-year 2026 guidance, including detailed performance metrics across business segments (U.S., AME, APMEA) and product categories, with mid-teens revenue growth expectations for H1 and full-year 2026.
View raw filing on EDGAR →MSC INDUSTRIAL DIRECT CO INC (MSM)
MSC Industrial Direct issued a press release on July 1, 2026 announcing financial results for fiscal 2026 third quarter ended May 30, 2026. The disclosure includes detailed financial highlights (net sales of $1,047.1M up 7.8% YoY, diluted EPS of $1.44 vs. $1.02 prior year), condensed consolidated financial statements, and forward guidance for Q4 and full-year fiscal 2026. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →CION Investment Corp (CICB)
CION Investment Corporation announced the scheduling of its second quarter 2026 earnings release and conference call for August 6, 2026 at 11:00 a.m. ET, providing investors with notice of when financial results for the quarter ended June 30, 2026 will be disclosed.
View raw filing on EDGAR →Biophytis SA
This exhibit is a press release announcing Biophytis's provisional, unaudited financial results for fiscal year 2025, including net loss of €7.8 million, cash position of €190 thousand, and a going-concern disclosure. While the results are presented as "provisional" pending audit completion, the disclosure of annual financial results, material uncertainty regarding going concern, and strategic updates constitute a material earnings announcement that would affect a reasonable investor's assessment of the company's financial condition and viability.
View raw filing on EDGAR →TEL INSTRUMENT ELECTRONICS CORP
This is a clear earnings release disclosing financial results for fiscal year ended March 31, 2025. The company issued a press release on June 30, 2026, reporting a net loss of $4.9M on revenues of $9.3M, with detailed consolidated balance sheets and statements of operations attached as Exhibit 99.1. The disclosure includes material financial metrics (gross margin decline of 24 percentage points, operating loss of $2.3M vs. prior year operating income of $737K) and forward-looking guidance, making it material to investors' assessment of the registrant's financial condition.
View raw filing on EDGAR →Blue Owl Capital Corp (OBDC)
Blue Owl Capital Corporation issued a press release announcing the scheduled release of its financial results for Q2 2026 (ending June 30, 2026) on August 5, 2026, along with a conference call on August 6, 2026. While this is technically an announcement of a future earnings release rather than the release of actual results, Item 2.02 disclosures of earnings announcements and scheduled earnings calls are classified as earnings_release events. The filing includes the full press release as Exhibit 99.1.
View raw filing on EDGAR →Blue Owl Technology Finance Corp. (OTF)
The filing discloses a scheduled announcement of financial results for Q2 2026 (ended June 30, 2026) to be released on August 5, 2026, with an accompanying earnings webcast on August 6, 2026. Although the actual results are not yet disclosed in this 8-K, the press release announces the timing and logistics of the earnings release and conference call, which is the standard form of earnings_release disclosure under Item 2.02. This is material to investors as it relates to the company's quarterly financial performance.
View raw filing on EDGAR →GREENBRIER COMPANIES INC (GBX)
The filing discloses Greenbrier's third fiscal quarter financial results for the period ended May 31, 2026, including revenue of $576.5M, net earnings of $18.9M ($0.60 diluted EPS), and EBITDA of $69.1M. The earnings release is furnished as Exhibit 99.1 and incorporated into Item 2.02, which is the standard Item for quarterly earnings disclosures. Material metrics such as gross margin improvement (230 basis points sequentially), lease fleet growth to 20,600 units, and updated fiscal 2026 guidance are disclosed.
View raw filing on EDGAR →FRANKLIN COVEY CO (FC)
Franklin Covey disclosed its third quarter fiscal 2026 financial results on July 1, 2026, reporting consolidated revenue of $67.8 million, net income of $3.1 million (versus a prior-year loss), Adjusted EBITDA of $8.3 million with 14% growth, and revised full-year fiscal 2026 guidance.
View raw filing on EDGAR →CULP INC (CULP)
This is a clear earnings release disclosing Culp Inc.'s fourth quarter and full fiscal year 2026 financial results. The Item 2.02 filing explicitly states "Culp, Inc. issued a news release to announce financial results for its fourth quarter and fiscal year ended May 3, 2026," with the full press release attached as Exhibit 99.1. The disclosure includes consolidated net sales, gross profit, operating loss, net loss per share, and segment performance metrics, along with forward guidance for fiscal 2027.
View raw filing on EDGAR →Can-Fite BioPharma Ltd. (CANF)
This is a clinical trial results announcement for Namodenoson in a Phase 2a pancreatic cancer study. While it discloses positive safety and survival outcomes, it is not a financial earnings release (no quarterly or annual financial results). The disclosure is material to investors as it reports clinical progress on a key pipeline asset, but the event_type taxonomy does not contain a specific category for clinical trial results or product development milestones. This is an operational/strategic disclosure about drug development progress that does not fit neatly into the provided categories.
View raw filing on EDGAR →BASSETT FURNITURE INDUSTRIES INC (BSET)
This is a clear earnings release disclosing Bassett Furniture's second quarter financial results for the fiscal year ending November 28, 2026. The Item 2.02 filing includes a news release (Exhibit 99.1) announcing Q2 results with detailed financial statements, segment information, and management commentary. The disclosure covers revenues ($83.8M), operating income ($2.2M), gross margin (56.5%), diluted EPS ($0.24), and cash flow metrics, making it a standard quarterly earnings announcement material to investors.
View raw filing on EDGAR →Locafy Ltd (LCFYW)
This exhibit is a press release announcing Locafy's financial results for the nine-month period ended March 31, 2026. The document explicitly states "Locafy Reports 31% Revenue Growth for the First Nine Months of Fiscal 2026" and provides detailed financial highlights including subscription revenue growth of 36%, operating expense reductions of 13%, and net loss improvement of 36%. The release includes consolidated financial statements (profit/loss, balance sheet, and cash flows) and management commentary from the CEO. This is a discrete earnings announcement, not a periodic financial report filing itself, and is material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Athene Holding Ltd. (ATH-PE)
Athene disclosed preliminary estimates of alternative net investment income of $350 million pre-tax with a 9% annualized return for Q2 2026 as a Regulation FD disclosure prior to Apollo's full earnings release on August 4, 2026. This constitutes an early release of material quarterly financial results and key performance metrics.
View raw filing on EDGAR →GENERAL MILLS INC (GIS)
General Mills issued a press release on July 1, 2026 reporting financial results for its quarter and fiscal year ended May 31, 2026. The disclosure includes detailed quarterly and full-year results covering net sales, operating profit, diluted EPS, segment performance, and forward guidance. This is a standard earnings release disclosing quarterly and annual financial results, which is material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →FACTSET RESEARCH SYSTEMS INC (FDS)
FactSet disclosed its third quarter fiscal 2026 financial results via press release on July 1, 2026, reporting GAAP revenues of $622.9 million (up 6.4% YoY), organic ASV growth of 7.1%, and adjusted diluted EPS of $4.53 (up 6.1% YoY). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the earnings release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →UNIFIRST CORP (UNF)
UniFirst issued a press release on July 1, 2026 announcing financial results for the third quarter of fiscal 2026 ended May 30, 2026. The disclosure includes consolidated revenues of $634.4 million, operating income of $23.0 million, net income of $19.9 million, and diluted EPS of $1.09, along with detailed segment reporting and balance sheet information. This is a standard quarterly earnings release attached as Exhibit 99 to the 8-K filing under Item 2.02.
View raw filing on EDGAR →Apollo Global Management, Inc. (APOS)
Apollo Global Management disclosed preliminary estimates of alternative net investment income of $350 million pre-tax with a 9% annualized return for Q2 2026 via Regulation FD disclosure, prior to its full earnings release scheduled for August 4, 2026.
View raw filing on EDGAR →CONSTELLATION BRANDS, INC. (STZ)
Constellation Brands disclosed Q1 FY2027 financial results (ended May 31, 2026) with reported EPS of $3.79 and comparable EPS of $3.43, net sales of $2,433 million, and operating income of $845 million across Beer and Wine and Spirits segments, along with updated fiscal 2027 guidance and a quarterly cash dividend of $1.03 per share.
View raw filing on EDGAR →NIKE, Inc. (NKE)
This is a clear earnings release disclosing NIKE's fiscal 2026 fourth quarter and full-year financial results. The press release, furnished as Exhibit 99.1, reports full-year revenues of $46.4 billion (flat reported, down 2% currency-neutral), net income of $3.1 billion (down 3%), and diluted EPS of $2.10 (down 3%), along with detailed income statements, balance sheets, and divisional revenue breakdowns. This is a material disclosure affecting investor assessment of the company's financial performance and position.
View raw filing on EDGAR →PROGRESS SOFTWARE CORP /MA (PRGS)
Progress Software issued a press release on June 30, 2026 announcing financial results for the fiscal second quarter ended May 31, 2026, reporting revenue of $253 million (7% YoY growth), diluted EPS of $0.50 (28% increase), and updated full-year 2026 guidance with increased revenue and EPS expectations.
View raw filing on EDGAR →LABCORP HOLDINGS INC. (LH)
The disclosure announces Labcorp's intention to release second quarter 2026 financial results on July 30, 2026, with a conference call and webcast to discuss results. The press release explicitly states "Labcorp to Announce Second Quarter Financial Results" and references the earnings press release and accompanying financial information that will be posted. This is a standard earnings announcement disclosure, material to investors as it provides notice of when quarterly financial results will be publicly disclosed.
View raw filing on EDGAR →AC Immune SA (ACIU)
This is a clinical trial data announcement press release disclosing interim 12-month results from the Phase 1b/2 ABATE trial of ACI-24. While not traditional financial earnings, the disclosure of clinical trial progress, safety data, and dose-response results for a lead therapeutic candidate is material to investors in a clinical-stage biopharmaceutical company. The announcement also references a $12 million milestone payment from Takeda triggered by dosing in Cohort AD4, which is a material financial event. The press release format and disclosure of interim trial results align with how clinical-stage biotech companies communicate material operational and financial developments to investors.
View raw filing on EDGAR →Pacific Coast Oil Trust
Pacific Coast Oil Trust issued a press release on June 30, 2026, announcing its monthly net profits interest calculations for April 2026, disclosing operating income, revenues, expenses, and realized prices for its underlying properties. This is a routine monthly financial disclosure typical of royalty trusts, though the filing also contains material adverse information (no distribution, going-concern implications, and pending litigation) that elevates the overall materiality of the disclosure.
View raw filing on EDGAR →ALAMOS GOLD INC (AGI)
This is a notice announcing the release of second quarter 2026 financial results on July 29, 2026, with a management conference call scheduled for July 30, 2026. Although the actual results are not yet disclosed in this exhibit, the document explicitly states "plans to release its second quarter 2026 financial results," making this a notice of an upcoming earnings release. Quarterly financial results are material to investors' assessment of the registrant's operational and financial performance.
View raw filing on EDGAR →Algoma Steel Group Inc. (ASTLW)
This is a media release dated June 30, 2026, in which Algoma Steel provides forward-looking guidance for Q2 2026 financial results, including expected steel shipments (175,000–180,000 tons) and Adjusted EBITDA ($5–$15 million). While technically guidance rather than reported results, the disclosure of quarterly financial expectations in a press release format is functionally equivalent to an earnings release and would materially affect investor assessment of the company's near-term performance and operational trajectory.
View raw filing on EDGAR →GreenTree Hospitality Group Ltd. (GHG)
This exhibit is a press release announcing GreenTree Hospitality Group's first quarter 2026 financial results. It discloses total revenues of RMB227.7 million (down 14.0% YoY), net income of RMB14.0 million (up from RMB7.8 million), and operational metrics for hotels and restaurants. The document explicitly states "GreenTree Hospitality Group Ltd. Reports First Quarter of 2026 Financial Results" and provides detailed quarterly financial performance, making it a classic earnings release. Material to investors as it reports quarterly results and forward guidance indicating expected revenue decline of -10% to -15% for organic hotel business.
View raw filing on EDGAR →QDM International Inc. (QDMI)
The 8-K discloses QDM International Inc.'s financial results for the fiscal year and fourth quarter ended March 31, 2026, via a press release furnished as Exhibit 99.1. Item 2.02 explicitly states the company "issued a press release announcing its financial results," with consolidated balance sheets and statements of operations showing significant growth: revenue increased 179.2% year-over-year, net income increased 56.22%, and basic EPS rose from $0.56 to $0.88. This is a standard earnings release disclosure material to investors.
View raw filing on EDGAR →Acco Group Holdings Ltd (ACCL)
This is a press release announcing unaudited financial results for the six months ended December 31, 2025. The document discloses revenue, costs, operating expenses, net income, and detailed segment performance (corporate secretarial, accounting, and IP registration services). The company reports net income of $94,197 versus $561,317 in the prior-year period—an 83.2% decline—driven by a 119.1% increase in administrative expenses related to IPO preparation and completion. This is a discrete earnings announcement, not a periodic financial report filing itself.
View raw filing on EDGAR →Linkage Global Inc (LGCB)
This is a press release dated June 30, 2026, announcing unaudited financial results for the six months ended March 31, 2026. The exhibit discloses selected financial metrics (revenues, gross profit, net loss) and detailed results across multiple business segments (cross-border sales, integrated e-commerce services, headset licensing). This is a discrete earnings announcement, not a periodic financial report itself, and is material to investors assessing the registrant's financial performance and operational trends.
View raw filing on EDGAR →Texxon Holding Ltd (NPT)
This is an earnings press release dated June 30, 2026, announcing unaudited financial results for the first half of fiscal year 2026 (six months ended December 31, 2025). The exhibit contains a detailed financial summary with revenue, gross profit, net loss, and EPS figures, along with management commentary and full unaudited condensed consolidated financial statements. The disclosure is material as it shows significant operational deterioration: revenue declined 35.8% to $327.0 million, the company swung from net income of $2.3 million to a net loss of $1.0 million, and gross margin compressed from 0.8% to 0.4%, reflecting challenging market conditions and competitive pricing pressures.
View raw filing on EDGAR →Allegiant Travel CO (ALGT)
The filing discloses second quarter 2026 adjusted earnings per share guidance for the combined Allegiant-Sun Country entity ($1.251 per share), representing a material update to previously issued standalone guidance (adjusted loss of $0.50 per share). While technically furnished under Item 8.01 (Other Events) rather than Item 2.02, the substance is a forward-looking earnings disclosure with specific per-share metrics, key assumptions (fuel cost, tax rate, share count), and explicit comparison to prior guidance—hallmarks of an earnings release or earnings guidance update material to investors.
View raw filing on EDGAR →Fast Track Group (FTRK)
This exhibit is a press release announcing audited financial and operational results for Fast Track Group's fiscal year ended February 28, 2026. The disclosure includes consolidated balance sheets, statements of operations, and cash flows, along with CEO commentary on business performance and outlook. Total revenues increased 112% to $1.7 million, gross profit increased 543%, and the company reported a net loss of $4.8 million. This is a discrete earnings announcement, not a periodic financial report filing itself, and is material to investors assessing the registrant's financial condition and operational trajectory.
View raw filing on EDGAR →EQUATOR Beverage Co (MOJO)
The filing discloses unaudited quarterly financial results for Q2 2026 via a press release issued July 1, 2026, showing 13% revenue growth to $1,247,635 and 30% net income increase to $199,008. This is a standard earnings release disclosure, typically material to investors assessing the registrant's financial performance and operational trajectory.
View raw filing on EDGAR →HARMONY GOLD MINING CO LTD (HGMCF)
This is a pre-year-end CEO update disclosing FY26 operational and financial performance: gold production guidance met for the 11th consecutive year (1.4–1.5 million ounces), CSA copper mine results, Eva Copper project progress, and record R4.4 billion in shareholder dividends over 12 months. While not a full audited earnings release (the filing notes the financial information has not been reviewed by external auditors), it is a substantive disclosure of annual results and operational metrics that would materially affect a reasonable investor's assessment of the registrant's performance and financial position.
View raw filing on EDGAR →KLX Energy Services Holdings, Inc. (KLXE)
KLX Energy Services disclosed Q1 2026 financial results, reporting quarterly revenue of $145 million, LTM revenue of $627 million, net loss of $73 million, and Adjusted EBITDA of $73 million, along with segment breakdown and operational highlights.
View raw filing on EDGAR →Micware Co., Ltd. (MWC)
Micware Co., Ltd. announced fiscal year 2026 financial results (year ended February 28, 2026), disclosing revenue of JPY 21.9 billion (up 3.7%), operating profit up 9.4%, and net income attributable to ordinary shareholders up 20.4%, with comprehensive segment analysis and management commentary.
View raw filing on EDGAR →AIR T INC (AIRTP)
Air T, Inc. issued a press release on June 29, 2026 announcing its financial results for the fiscal year ended March 31, 2026. The disclosure includes comprehensive financial metrics (revenues of $327.1 million, operating loss of $11.2 million, net income per share of $28.85), segment-by-segment performance analysis, and adjusted EBITDA reconciliation. This is a standard annual earnings release furnished as Exhibit 99.1 under Item 2.02, which is the designated Item for results of operations and financial condition.
View raw filing on EDGAR →AIR T INC (AIRTP)
AIR T disclosed comprehensive financial results for FY26 (twelve-month period ended March 31, 2026) with consolidated revenue of $327.1M and Adjusted EBITDA of $10.1M, along with segment-by-segment performance metrics in an investor presentation attached as an exhibit.
View raw filing on EDGAR →HONEYWELL INTERNATIONAL INC (HON)
The filing furnishes supplemental recast financial information for continuing operations in connection with the Aerospace Technologies spin-off completion, including quarterly and annual segment data for 2024, 2025, and Q1 2026 presented on a continuing-operations basis. The press release and supplemental financial exhibits provide historical segment results reflecting discontinued operations treatment material to investors assessing the post-spin company's performance.
View raw filing on EDGAR →Replimune Group, Inc. (REPL)
This is a clear earnings release disclosing Replimune's financial results for the fiscal fourth quarter and year ended March 31, 2026. The Item 2.02 filing includes a news release (Exhibit 99.1) announcing consolidated statements of operations, balance sheet data, and detailed financial metrics including R&D expenses ($221.2M), SG&A expenses ($98.7M), and net loss ($313.9M). The disclosure is material as it provides investors with comprehensive financial performance data for the fiscal year.
View raw filing on EDGAR →iHuman Inc. (IH)
This exhibit is a press release announcing iHuman Inc.'s unaudited financial results for the first quarter ended March 31, 2026. It discloses quarterly revenues (RMB182.5 million), gross profit, operating loss, and net income, along with key operational metrics (MAUs) and management commentary. The document explicitly states "iHuman Inc. Announces First Quarter 2026 Unaudited Financial Results" and includes detailed financial tables and forward-looking statements typical of an earnings release. While the results show declining revenues and a shift from operating income to operating loss year-over-year, the disclosure of quarterly financial results is a material event affecting investor assessment of the registrant's performance.
View raw filing on EDGAR →AeroVironment Inc (AVAV)
AeroVironment issued a press release on June 29, 2026 announcing fourth quarter and fiscal year 2026 financial results, including record revenue of $641.6 million for Q4 and $1,976.8 million for the full year (up 133% and 141% year-over-year respectively), net income of $63.2 million for Q4, and forward guidance for fiscal 2027.
View raw filing on EDGAR →GOLAR LNG LTD (GLNG)
This is an announcement of Golar LNG's Q2 2026 financial results release scheduled for August 13, 2026, with details on how to access the webcast presentation and conference call. Although the exhibit itself is a procedural notice rather than the results document itself, it announces the imminent disclosure of quarterly financial results, which is a material event that would affect investor assessment of the registrant's financial performance and position.
View raw filing on EDGAR →Abivax S.A. (AAVXF)
This is a press release announcing topline results from ABTECT Maintenance Part 2, a Phase 3 clinical trial of obefazimod for ulcerative colitis. The disclosure reports efficacy and safety data from a material clinical milestone—specifically, positive results in a refractory patient population and expanded safety database—that would affect a reasonable investor's assessment of the company's lead drug candidate and regulatory pathway. The company explicitly states it remains "on track to submit its NDA to the U.S. Food and Drug Administration in the fourth quarter of 2026," making these trial results directly relevant to near-term value drivers. While this is not a financial earnings release in the traditional sense, it is a material clinical results announcement that functions as a discrete event disclosure of significant business importance.
View raw filing on EDGAR →NeuroSense Therapeutics Ltd. (NRSNW)
This is a press release announcing positive Phase 2b clinical trial results for NeuroSense's lead drug candidate PrimeC in ALS. The disclosure reports achievement of the primary efficacy endpoint (statistically significant TDP-43 reduction, p=0.0421), previously reported clinical outcomes including slowing of disease progression and survival benefit, and advancement toward Phase 3 trials. While not a financial earnings release in the traditional sense, this is a material clinical milestone disclosure that would significantly affect investor assessment of the company's pipeline value and prospects. The language ("achieved primary endpoint," "statistically significant," "compelling body of evidence") and the detailed clinical data presentation mirror the structure and materiality of an earnings-type announcement for a clinical-stage biotech company.
View raw filing on EDGAR →